Major pathological remissions in a patient with stage IIIA nonsmall cell lung cancer after neoadjuvant tislelizumab combined with chemotherapy: a case report and literature review.

Anti-cancer drugs(2023)

引用 0|浏览0
暂无评分
摘要
Our case study contributes to the existing evidence on the feasibility, efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced unresectable NSCLC.
更多
查看译文
关键词
case report, immunotherapy, neoadjuvant therapy, non-small cell lung cancer, tislelizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要